Estrogen receptor beta agonist diarylpropiolnitrile (DPN) does not mediate neuroprotection in a rat model of permanent focal ischemia

Brain Research

Volumn 1185, Issue 1, 2007, Pages 275-282

  Farr, Tracy D ^a   Carswell, Hilary V O ^a   Gsell, Willy ^a   Macrae, I Mhairi ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Behavior; DPN; Estrogen receptor beta; Neuroprotection; Stroke

Indexed keywords

DIARYLPROPIOLNITRILE; ESTROGEN RECEPTOR BETA; NITRILE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FORELIMB; HEMISPHERE; HISTOPATHOLOGY; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSMOTIC MINIPUMP; OVARIECTOMY; PRIORITY JOURNAL; RAT; RAT STRAIN; SCORING SYSTEM; SENSORIMOTOR FUNCTION; STROKE;

ANALYSIS OF VARIANCE; ANIMALS; DISEASE MODELS, ANIMAL; ESTROGEN ANTAGONISTS; FEMALE; INFARCTION, MIDDLE CEREBRAL ARTERY; MAGNETIC RESONANCE IMAGING; NEUROLOGIC EXAMINATION; NITRILES; OVARIECTOMY; PROPIONATES; PSYCHOMOTOR PERFORMANCE; RATS; SEVERITY OF ILLNESS INDEX;

ANIMALIA; RATTUS;

EID: 36448946877     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.09.009     Document Type: Article

References (38)

1. Bingham D., Macrae I.M., and Carswell H.V. Detrimental effects of 17beta-oestradiol after permanent middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 25 (2005) 414-420
2. Brown A.W. Structural abnormalities in neurons. J. Clin. Pathol. 30 (1977) 155-169
3. Carswell H.V., Bingham D., Wallace K., Nilsen M., Graham D.I., Dominiczak A.F., and Macrae I.M. Differential effects of 17beta-estradiol upon stroke damage in stroke prone and normotensive rats. J. Cereb. Blood Flow Metab. 24 (2004) 298-304
4. Carswell H.V., Macrae I.M., Gallagher L., Harrop E., and Horsburgh K.J. Neuroprotection by a selective estrogen receptor beta agonist in a mouse model of global ischemia. Am. J. Physiol. Heart Circ. Physiol. 287 (2004) H1501-H1504
5. Cordey M., and Pike C.J. Neuroprotective properties of selective estrogen receptor agonists in cultured neurons. Brain Res. 1045 (2005) 217-223
6. Curtis Hewitt S., Couse J.F., and Korach K.S. Estrogen receptor transcription and transactivation: estrogen receptor knockout mice - what their phenotypes reveal about mechanisms of estrogen action. Breast Cancer Res. 2 (2000) 345-352
7. Dai X., Chen L., and Sokabe M. Neurosteroid estradiol rescues ischemia-induced deficit in the long-term potentiation of rat hippocampal CA1 neurons. Neuropharmacology 52 (2007) 1124-1138
8. Dubal D.B., Zhu H., Yu J., Rau S.W., Shughrue P.J., Merchenthaler I., Kindy M.S., and Wise P.M. Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 1952-1957
9. Dubal D.B., Rau S.W., Shughrue P.J., Zhu H., Yu J., Cashion A.B., Suzuki S., Gerhold L.M., Bottner M.B., Dubal S.B., Merchanthaler I., Kindy M.S., and Wise P.M. Differential modulation of estrogen receptors (ERs) in ischemic brain injury: a role for ERalpha in estradiol-mediated protection against delayed cell death. Endocrinology 147 (2006) 3076-3084
10. Farr T.D., Carswell H.V., Gallagher L., Condon B., Fagan A.J., Mullin J., and Macrae I.M. 17beta-Estradiol treatment following permanent focal ischemia does not influence recovery of sensorimotor function. Neurobiol. Dis. 23 (2006) 552-562
11. Frasor J., Barnett D.H., Danes J.M., Hess R., Parlow A.F., and Katzenellenbogen B.S. Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) alpha activity by ERbeta in the uterus. Endocrinology 144 (2003) 3159-3166
12. Gerriets T., Stolz E., Walberer M., Muller C., Kluge A., Bachmann A., Fisher M., Kaps M., and Bachmann G. Noninvasive quantification of brain edema and the space-occupying effect in rat stroke models using magnetic resonance imaging. Stroke 35 (2004) 566-571
13. Gibson C.L., Gray L.J., Murphy S.P., and Bath P.M. Estrogens and experimental ischemic stroke: a systematic review. J. Cereb. Blood Flow Metab. (2006)
14. Gordon K.B., Macrae I.M., and Carswell H.V. Effects of 17beta-oestradiol on cerebral ischaemic damage and lipid peroxidation. Brain Res. 1036 (2005) 155-162
15. Harrington W.R., Sheng S., Barnett D.H., Petz L.N., Katzenellenbogen J.A., and Katzenellenbogen B.S. Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Mol. Cell. Endocrinol. 206 (2003) 13-22
16. Harukuni I., Hurn P.D., and Crain B.J. Deleterious effect of beta-estradiol in a rat model of transient forebrain ischemia. Brain Res. 900 (2001) 137-142
17. Hunter A.J., Hatcher J., Virley D., Nelson P., Irving E., Hadingham S.J., and Parsons A.A. Functional assessments in mice and rats after focal stroke. Neuropharmacology 39 (2000) 806-816
18. Hurn P.D., and Macrae I.M. Estrogen as a neuroprotectant in stroke. J. Cereb. Blood Flow Metab. 20 (2000) 631-652
19. Imai H., Graham D.I., Masayasu H., and Macrae I.M. Antioxidant ebselen reduces oxidative damage in focal cerebral ischemia. Free Radic. Biol. Med. 34 (2003) 56-63
20. Kuiper G.G., Enmark E., Pelto-Huikko M., Nilsson S., and Gustafsson J.A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 5925-5930
21. Le Saux M., Morissette M., and Di Paolo T. ERbeta mediates the estradiol increase of D(2) receptors in rat striatum and nucleus accumbens. Neuropharmacology 50 (2006) 451-457
22. Leker R.R., Teichner A., Grigoriadis N., Ovadia H., Brenneman D.E., Fridkin M., Giladi E., Romano J., and Gozes I. NAP, a femtomolar-acting peptide, protects the brain against ischemic injury by reducing apoptotic death. Stroke 33 (2002) 1085-1092
23. Lund T.D., Rovis T., Chung W.C., and Handa R.J. Novel actions of estrogen receptor-beta on anxiety-related behaviors. Endocrinology 146 (2005) 797-807
24. Matucz E., Moricz K., Gigler G., Benedek A., Barkoczy J., Levay G., Harsing Jr. L.G., and Szenasi G. Therapeutic time window of neuroprotection by non-competitive AMPA antagonists in transient and permanent focal cerebral ischemia in rats. Brain Res. 1123 (2006) 60-67
25. Meyers M.J., Sun J., Carlson K.E., Marriner G.A., Katzenellenbogen B.S., and Katzenellenbogen J.A. Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J. Med. Chem. 44 24 (2001) 4230-4251
26. Miller N.R., Jover T., Cohen H.W., Zukin R.S., and Etgen A.M. Estrogen can act via estrogen receptor alpha and beta to protect hippocampal neurons against global ischemia-induced cell death. Endocrinology 146 (2005) 3070-3079
27. Murphy S.J., McCullough L.D., and Smith J.M. Stroke in the female: role of biological sex and estrogen. ILAR J. 45 (2004) 147-159
28. Paxinos G., and Watson C. The Rat Brain in Stereotactic Coordinates. 4th ed. (1998), Academic Press, San Diego, California
29. Roesch D.M. Effects of selective estrogen receptor agonists on food intake and body weight gain in rats. Physiol. Behav. 87 (2006) 39-44
30. Sampei K., Goto S., Alkayed N.J., Crain B.J., Korach K.S., Traystman R.J., Demas G.E., Nelson R.J., and Hurn P.D. Stroke in estrogen receptor-alpha-deficient mice. Stroke 31 (2000) 738-743 (discussion 744)
31. Sanchez-Criado J.E., Martin De Las Mulas J., Bellido C., Tena-Sempere M., Aguilar R., and Blanco A. Biological role of pituitary estrogen receptors ERalpha and ERbeta on progesterone receptor expression and action and on gonadotropin and prolactin secretion in the rat. Neuroendocrinology 79 (2004) 247-258
32. Sawada M., Alkayed N.J., Goto S., Crain B.J., Traystman R.J., Shaivitz A., Nelson R.J., and Hurn P.D. Estrogen receptor antagonist ICI182,780 exacerbates ischemic injury in female mouse. J. Cereb. Blood Flow Metab. 20 (2000) 112-118
33. Schallert T., Fleming S.M., Leasure J.L., Tillerson J.L., and Bland S.T. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39 (2000) 777-787
34. Shughrue P.J., Lane M.V., and Merchenthaler I. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J. Comp. Neurol. 388 (1997) 507-525
35. Tamura A., Graham D.I., McCulloch J., and Teasdale G.M. Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 1 (1981) 53-60
36. Theodorsson A., and Theodorsson E. Estradiol increases brain lesions in the cortex and lateral striatum after transient occlusion of the middle cerebral artery in rats: no effect of ischemia on galanin in the stroke area but decreased levels in the hippocampus. Peptides 26 (2005) 2257-2264
37. van de Stolpe A., Slycke A.J., Reinders M.O., Zomer A.W., Goodenough S., Behl C., Seasholtz A.F., and van der Saag P.T. Estrogen receptor (ER)-mediated transcriptional regulation of the human corticotropin-releasing hormone-binding protein promoter: differential effects of ERalpha and ERbeta. Mol. Endocrinol. 18 (2004) 2908-2923
38. Zhao L., Wu T.W., and Brinton R.D. Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons. Brain Res. 1010 (2004) 22-34